3 ms·
The title in HN is inaccurate. Having a 1% higher score on one metric is not beating a previously published model. This is a replicate, which is fine enough.
by pama 2y ago
The title in HN is inaccurate. Having a 1% higher score on one metric is not beating a previously published model. This is a replicate, which is fine enough.
- drob 2y agoFwiw, the authors never actually claimed this. From their technical report [0]: > Chai-1 achieves a ligand RMSD success rate of 77%, which is comparable to the 76% achieved by AlphaFold3 [0] https://chaiassets.com/chai-1/paper/technical_report_v1.pdf https://chaiassets.com/chai-1/paper/technical_report_v1.pdf
- dang 2y agoAh yes - thanks! We've changed it to the article title now. Submitters: "Please submit the original source. If a post reports on something found on another site, submit the latter." - https://news.ycombinator.com/newsguidelines.html https://news.ycombinator.com/newsguidelines.html (Submitted title was "Chai-1 Defeats AlphaFold 3")